Introduction {#sec0001}
============

The pneumonia of unknown etiology occurred in December, 2019 in Wuhan, Hubei Province, China, has been confirmed to be caused by a novel coronavirus.[@bib0001], [@bib0002], [@bib0003] The newly identified virus has been recently named \"severe acute respiratory syndrome coronavirus 2″ (SARS-CoV-2), and the disease caused by SARS-CoV-2 was designated coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO).[@bib0004] The SARS-CoV-2 is the seventh member of enveloped RNA coronavirus besides coronavirus 229E, OC43, NL63, HKU1, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV).[@bib0001] The initial clusters of patients with COVID-19 pneumonia were epidemiologically linked to local seafood market in Wuhan, and person-to-person transmission was subsequently confirmed.[@bib0005], [@bib0006], [@bib0007] It has rapidly spread globally. As of February 18, 72,532 cases were laboratory-confirmed and clinically-diagnosed, and 6242 were suspected in China.[@bib0008] The reproductive number (R0), defined as the expected number of secondary infectious cases generated by an infectious case in a susceptible population, is estimated to 3.77.[@bib0009]

Recent publications have depicted the epidemiological and clinical characteristics of patients infected with SARS-CoV-2.[@bib0002] ^,^ [@bib0003] ^,^ [@bib0007] ^,^ [@bib0009], [@bib0010], [@bib0011] The definite diagnosis of COVID-19 is expected with the novel coronavirus nucleic acid positive in swabs, sputum, or secretions from the lower respiratory tract, or blood by real-time reverse transcription polymerase chain reaction assay (RT-PCR). However, the new coronavirus nucleic acid kits are in short supply and time-consuming in manipulation. Furthermore, false negatives may exist in some cases due to the insufficient viral materials in the specimen. Recent studies have reported the cases with initial SARS-CoV-2 negative but typical CT findings,[@bib0012] ^,^ [@bib0013] however, most of them turned out to be positive after repeated tests for SARS-CoV-2 nucleic acid. Therefore, chest CT imaging plays a critical role in the surveillance and diagnosis of COVID-19 pneumonia with a higher sensitivity and efficiency than the chest X-rays do. Guan et al. also reported that 76.4% cases with viral pneumonia findings at CT were verified COVID-19.[@bib0011] Based on the epidemiological characteristics of COVID-19 pneumonia, patients with typical CT imaging features in Hubei Province will be grouped as clinically-diagnosed cases, contributing to the total number of confirmed diagnosis according to the "Diagnosis and Treatment for COVID-19 Pneumonia (Fifth Trial Version)" released by the National Health Commission (NHC) of China since February 12, 2020.[@bib0014]

Pregnant women are more susceptible to infectious diseases due to the immune suppression.[@bib0015] Previous studies found that there was a male-dominated tendency and few cases occurred in children for COVID-19 pneumonia.[@bib0003] ^,^ [@bib0009] To the best of our knowledge, there are few published data involving the clinical and chest CT findings of COVID-19 pneumonia in pregnant women and children.[@bib0016] ^,^ [@bib0017] In this present study, the clinical and chest CT findings of COVID-19 pneumonia were investigated for the pregnant women and children in comparison with non-pregnant adults from two centers. The CT features were further compared between the laboratory-confirmed and clinically-diagnosed pregnant groups, which could favor the surveillance and diagnosis.

Methods {#sec0002}
=======

Patients {#sec0003}
--------

This study was approved by the Institutional Ethics Committee of relevant centers. The informed consent requirement was waived for this retrospective study. Clinical and chest CT imaging data of 60 patients with laboratory-confirmed and clinically-diagnosed COVID-19 pneumonia were reviewed. One clinically-diagnosed patient was afterwards excluded for positive mycoplasma infection. Finally, a total of 59 patients from two centers were recruited in this study, in which three non-pregnant adults were from Xinhua Hospital and the other patients from Maternal and Child Health Hospital of Hubei Province including 41 pregnant women, 11 non-pregnant adults, and 4 children. For the patients who underwent SARS-Cov-2 test, the throat swab samples were collected for RT-PCR in accordance with the WHO guideline.[@bib0018]

CT imaging acquisition {#sec0004}
----------------------

All the patients underwent non-enhanced chest CT examinations for detecting COVID-19 pneumonia in the supine position during end-inspiration. The CT scans of non-pregnant adults were performed with a 64-section multi-detector CT scanner (uCT780, United imaging, Shanghai, China, or Optima 660, GE Medical System, Milwaukee, WI, USA). The CT scans of pregnant women and children were all performed with the same 64-section multi-detector CT scanner (Optima 660, GE Medical System, Milwaukee, WI, USA). The protocols were as follows. For non-pregnant adults: tube voltage 120 kV, automatic tube current (120--380) mA, thickness (5--7) mm, slice interval 5 mm, rotation speed 0·5 s, and helical pitch 1·0875:1 or 1·375:1. For pregnant women: tube voltage 120 kV, automatic tube current (10--300) mA, thickness (7--10) mm, slice interval 5 mm, rotation speed 0·6 s, helical pitch 1·375:1, and noise index 15. Thyroid, abdomen, and plevis were protected by the lead sheath. The dose-length product (DLP) was 50--150 mGy·cm. For children: tube voltage 100 kV, automatic tube current (30-100) mA, thickness (3--5) mm, slice interval 1 mm, rotation speed 0·6 s, and helical pitch 0·969:1. Lung window images at 0·625 to 1 mm thickness were reconstructed. Iterative reconstruction technique was implemented. The informed consents for CT examination were obtained from all patients.

Image interpretation {#sec0005}
--------------------

The chest CT features of non-pregnant adults were reviewed by two radiologists (HL and JL, with 8 and 10 years of experience in thoracic imaging, respectively) in consensus. The chest CT features of pregnant women and children were reviewed by two radiologists (HL and FL, with 8 and 15 years of experience in thoracic imaging, respectively) in consensus. The disputes between the radiologists were resolved by consultation with another third experienced radiologist (DW or WL, with more than 25 years of experience in thoracic imaging, respectively).

CT features consisted of lesion number, distribution, as well as presence of ground-glass opacity (GGO), GGO with consolidation, GGO with reticulation from intralobular/interlobular septal thickening, consolidation, air bronchogram, cavitation, lymphadenopathy, and pleural effusion. GGO was defined as a hazy density increase in lung with vessels margins preservation, whereas consolidation was opacification with obscuring vessels margins.[@bib0019] The distribution included focal (one lesion either in unilateral or bilateral lungs), scattered (less than 10 lesions either in unilateral or bilateral lungs), and diffuse patterns (more than 10 lesions in bilateral lungs) and bilaterality and unilaterality which divided into the peripheral (the outer one-third of the lung) and central locations. Regarding the number of lesions, the lesion was counted as the involved lung segments if a lesion extends across multiple lung segments.[@bib0020] Lymphadenopathy was defined as the size of lymph node more than 10 mm in short-axis diameter.

In order to stratify the degree of lung involvement, a scoring method based on CT findings was implemented. Each of the lung lobe involvement was classified as none (0%), minimal (1%--25%), mild (26%--50%), moderate (51%--75%), or severe (76%--100%), the corresponding scores were 0,1,2,3, and 4, respectively. The final "total severity score" (TSS) was obtained by summing the scores of the five lobes. [@bib0021]

Statistical analysis {#sec0006}
--------------------

Statistical analysis was performed with SPSS 23.0 (IBM, New York, NY) and *P*\< 0·05 indicated a statistically significant difference. Quantitative variables were expressed as mean (standard deviation, SD). The one-way analysis of variance (ANOVA) and the Pearson Chi-squared test were used for the comparison of continuous data and categorical data among the non-pregnant adult group and the two pregnant groups.

Role of the funding source {#sec0007}
==========================

There was no funding source for this study.

Results {#sec0008}
=======

Clinical findings {#sec0009}
-----------------

Clinical findings of 55 adult patients were shown in [Table 1](#tbl0001){ref-type="table"} . Among the 41 pregnant women, the median age was 30 years old (range, 22--42 years). The gestational age ranged from 22 weeks to 40 weeks plus 5 days. Nineteen patients were admitted to hospital for delivery and 22 were outpatients. And four had gestational diabetes, 3 gestational hypertension, and 1 hepatitis B infection. Of them, 16 patients were laboratory-confirmed SARS-CoV-2 positive, 17 laboratory-negative but with typical CT features of COVID-19 pneumonia and the other 8 did not undergo SARS-CoV-2 test. Among the laboratory negative patients, SARS-CoV-2 RNA was tested three times in 2 patients, twice in 1 patient, and once in the other patients. The populations without SARS-CoV-2 positive were categorized into the clinically-diagnosed group. There were 9/16 (56%) and 16/25 (64%) patients presenting initial normal body temperature in the laboratory-confirmed and clinically-diagnosed pregnant groups, which was less common than the non-pregnant adults group (*P*\< 0·001). Totally 6 and 10 patients in the laboratory-confirmed and clinically-diagnosed pregnant groups underwent delivery, in which 5 and 9 patients presented post-partum low grade fever before CT examination. No significant differences existed for the other clinical symptoms in our study. All the pregnant women with COVID-19 were stratified as the mild or common types. No pregnant woman was admitted to the intensive care unit (ICU), and no clinical abnormalities were observed in the infants.Table 1Clinical and laboratory characteristics of 55 adult patients with COVID-19 pneumonia.Table 1CharacteristicsNumber (%)[\*](#tb1fn1){ref-type="table-fn"}*P* value[⁎⁎](#tb1fn2){ref-type="table-fn"}**Gender** Male5 (36%) / 0 (0%) / 0 (0%) Female9 (64%) / 16 (100%) / 25 (100%)**Age(years)**33·5 (27--58) / 30 (26--35) / 31 (22--42)0·001**Wuhan area**11 (79%) / 16 (100%) / 25 (100%)..**Initial Symptoms** Fever14 (100%) / 7 (44%) / 9 (36%)\< 0·001 Post-partum fever0 (0%) / 5 (31%) / 9 (36%)0·038 Cough9 (64%) / 6 (38%) / 9 (36%)0·195 Short of breath0 (0%) / 2 (13%) / 3 (12%)0·390 Fatigue2 (14%) / 3 (19%) / 2 (8%)0·590 Loss of appetite0 (0%) / 2 (13%) / 1 (4%)0·294 Diarrhea1 (7%) / 0 (0%) / 0 (0%)0·225**Laboratory test** Leukocytosis0 (0%) / 8 (50%) / 9 (36%)0·010 Leukopenia or normal14 (100%) / 8 (50%) / 16 (64%).. Elevated neutrophil ratio2 (14%) / 14 (88%) / 20 (80%)\< 0·001 Lymphopenia11 (79%) / 9 (56%) / 16 (64%)0·430 Decreased lymphocyte ratio12 (86%) / 16 (100%) / 22 (88%)0·315 Elevated C-reactive protein7 (50%) / 13 (81%) / 14 (56%)0·154[^2][^3]

The leukocytosis (50% and 36%) and elevated neutrophil ratio (88% and 80%) were more common in the laboratory-confirmed and clinically-diagnosed pregnant groups (*P* = 0·010, *P* \< 0·001) compared with the non-pregnant adult group (0% and 14%), while there was no significant difference for lymphopenia among the three groups.

As with the 14 non-pregnant adults, the most common symptoms were also fever (100%) and cough (64%). The clinical characteristics of the 4 children were shown in [Table 2](#tbl0002){ref-type="table"} , the blood test was non-specific. Two of them were sister and brother. One child was simultaneously with respiratory syncytial virus (RSV) and SARS-CoV-2 positive, while all the other adults and children were tested negative for mycoplasma pneumonia, chlamydia pneumonia, respiratory syncytial virus, adenovirus, coxsackie virus B, influenza A, influenza B, and human parainfluenza virus.Table 2Clinical and chest CT imaging characteristics of 4 children with laboratory-confirmed COVID-19 pneumonia.Table 2FindingsCase 1/Case2/Case3/Case4**Clinical characteristicsGender** Male/FemaleFemale/Male/Female/Male**Age**5 years/11 months/9 years/2 months**Exposure to confirmed or suspected patient**Yes/Yes/Yes/Yes**Initial Symptoms** FeverYes/Yes/Yes/No CoughYes/Yes/No/Yes FatigueYes/No/No/No**Other pathogen infection**No/No/No/Yes**Laboratory test** Blood leukocyte countDecreased/Normal/Normal/Normal Neutrophil ratioDecreased/Decreased/Normal/Normal Lymphocyte countIncreased/Increased/Normal/Normal Lymphocyte ratioIncreased/Increased/Decreased/Normal C-reactive proteinNormal/Normal/Normal/Increased**CT findings**Normal/Single consolidation/Single pure GGO/Multiple consolidations**Other findings** Pleural effusionNo/No/No/Yes LymphadenopathyNo/No/No/No[^4]

Chest CT features {#sec0010}
-----------------

The initial CT features were demonstrated in [Table 3](#tbl0003){ref-type="table"} . The median interval of CT scan from the onset of symptoms was 2 days (range, 1--8 days). Sixteen pregnant women underwent CT scans after delivery and the others prior to delivery. A total of 614 lesions were detected in the 55 adult patients. The lesions involved 174 lobes and 390 lung segments. There were 299 lesions (49%) located in the lower lobes and 488 (79%) located peripherally ([Fig. 1](#fig0001){ref-type="fig"} ). The most common lesions were pure GGO, GGO with consolidation, GGO with reticulation, and complete consolidation.Table 3Chest CT imaging characteristics of 55 adult patients with COVID-19 pneumonia.Table 3CharacteristicsNumber (%)[\*](#tb3fn1){ref-type="table-fn"}Lesion (%)[\*](#tb3fn1){ref-type="table-fn"}*P* value[⁎⁎](#tb3fn2){ref-type="table-fn"}**Location** No lesion0 (0%) / 3 (19%) / 0 (0%)0.. Unilateral lung3 (21%) / 3 (19%) / 9 (36%)10 (8%) / 7 (4%) / 26 (8%)0·303 Bilateral lungs11 (79%) / 10 (63%) / 16 (64%)121 (92%) /154 (96%) / 296 (92%)..**Lung lobe involvement** No lesion0 (0%) / 3 (19%) / 0 (0%)0.. One lobe1 (7%) / 2 (13%) / 8 (32%)3 (2%) / 2 (1%) / 14 (4%)0·149 Two lobes3 (21%) / 1 (6%) / 2 (8%)10 (8%) / 5 (3%) /24 (7%)0·144 Three lobes4 (29%) / 2 (13%) / 4 (16%)33 (25%) / 16 (10%) / 27 (8%)\< 0·001 Four lobes1 (7%) / 2 (13%) / 1 (4%)4 (3%) / 23 (14%) / 9 (3%)\< 0·001 Five lobes5 (36%) / 6 (38%) / 10 (40%)81 (62%) / 115 (71%) / 248 (77%)0·004**Predominant distribution** Peripheral14 (100%) / 16 (100%) /24 (96%)100 (76%) / 135 (84%) / 253 (79%)0·241 Central0 (0%) / 0 (0%) /1 (4%)31 (24%) / 26 (16%) / 69 (21%)..**Main presence of lesions** Pure GGO13 (93%) / 12 (75%) / 18 (72%)94 (72%) / 91 (57%) / 168 (52%)0·001 GGO with consolidation11 (79%) / 7 (44%) / 15 (60%)25 (19%) / 30 (19%) / 95 (30%)0·009 GGO with reticulation10 (71%) /6 (38%) / 4 (16%)24 (18%) / 9 (26%) /16 (5%)\< 0·001 Consolidation3 (21%) / 8 (50%) / 14 (56%)12 (9%) / 40 (25%) / 58 (18%)0·002**Other findings** Pleural effusion1 (7%) / 6 (38%) / 6 (24%)0.. Lymphadenopathy0 (0%) / 0 (0%) / 0 (0%)0..[^5][^6][^7]Fig. 1Chest CT images of a 29-year-old non-pregnant female with laboratory-confirmed COVID-19 pneumonia, presenting fever and cough for 2 days. (a) Axial thin-section CT showed the lesion was located in the peripheral region of left lower lobe, showing GGO with reticulation. (b) At the re-examined CT 6 days later, decreased size of the initial lesion and more GGOs with consolidation lesions were noted. (c) The second follow-up CT 7 days later, improvement with fewer lesions and decreased density were depicted.Fig. 1

Both the non-pregnant and the pregnant groups shared the same peripheral distribution of the lesions in the lungs ([Figs. 2](#fig0002){ref-type="fig"} and [3](#fig0003){ref-type="fig"} ) without significant difference (*P* = 0·241). However, consolidation including mixed GGO with consolidation and complete consolidation was significantly more frequent in the laboratory-confirmed and clinically-diagnosed pregnant groups compared to the non-pregnant adults (*P* = 0·007, *P* \< 0·001), while GGO and GGO with reticulation were more frequent in the non-pregnant adults (*P* = 0·001, *P* \< 0·001). No significant difference was found regarding consolidation between the two pregnant groups (*P* = 0·366). Focal and scattered distributions were presented in 0 (0%)/9 (56%), 1 (7%)/5 (31%), and 6 (43%)/9 (36%) patients in the non-pregnant adult, laboratory-confirmed pregnant, and clinically-diagnosed pregnant groups, respectively. Diffuse distribution was detected in 5 (36%), 7 (44%), and 10 (40%) patients in the above three groups, respectively. Then the mean involved lungs segments were 3·4 (SD 1·4), 3·0 (SD 2·0), and 3·1 (SD 1·8) in the three groups, while the mean involved pulmonary segments were 6·8 (SD 5·2), 6·3 (SD 4.9), and 7·8(SD 6·4). The TSS tended to be higher in the clinically-diagnosed group than that in the laboratory-confirmed group (4·8 \[SD 3·5\] vs. 4·4 \[SD3·3\]). The TSS in the non-pregnant adult group was 4·3 (SD 2·4), and there were no significant differences among the three groups (*P* = 0·882). In the laboratory-confirmed pregnant group, no pulmonary abnormalities associated with COVID-19 were found in three patients with post-partum fever, and CT just revealed mild pulmonary exudation and pleural effusion which could be referred to as the common post-partum findings. GGO with reticulation was detected in 10/14 (71%), 6/16 (38%), and 4/25 (16%) patients among the non-pregnant, laboratory-confirmed, and clinically-diagnosed pregnant groups (*P* \< 0·001), while 3/14 (21%), 7/16 (44%), and 9/25 (36%) for the air bronchogram.Fig. 2Chest CT images of three pregnant women with laboratory-confirmed COVID-19 pneumonia. (a) 28-year-old female with 34 weeks plus 5 days pregnancy, presenting fever and loss of appetite for 2 days, GGO with consolidation in peripheral distribution was detected at CT in the left upper lobe. (b) 30-year-old female with 33 weeks pregnancy, presenting fever and fatigue for 4 days, GGO with consolidation and reticulation were identified with peripheral distribution in the right lower lobe. (C) 30-year-old female with 31 weeks pregnancy, presenting fever and cough for 2 days, complete consolidations were detected with peripheral distribution in the lower lobes of bilateral lungs.Fig. 2Fig. 3Chest CT images of a 28-year-old female with 36 weeks plus 1 day pregnancy, with clinically-diagnosed COVID-19 pneumonia, presented post-partum low grade fever. (a) Baseline CT imaging demonstrated typical CT features of COVID-19 pneumonia, with multiple GGOs and GGOs with reticulation lesions predominantly peripheral distribution in both lungs. (b) Follow-up CT 10 days later after antiviral therapy, demonstrated improvement with fewer lesions and few consolidation lesions left.Fig. 3

The Chest CT findings of the children were also shown in [Table 2](#tbl0002){ref-type="table"}. One 2-month-old child with simultaneous RSV and SARS-CoV-2 infections demonstrated multiple focal consolidation lesions and pleural effusion ([Fig. 4](#fig0004){ref-type="fig"} ).Fig. 4Positive chest CT of 3 children with laboratory confirmation and atypical CT features of COVID-19 pneumonia. (a) 11-month-old child with fever, cough, and fatigue for 6 days. The only consolidation lesion was located in central region of the right lower lobe. (b) 9-year-old child with fever for 3 days. The only GGO lesion was located in the interlobular subpleural area of right middle lobe. (c) 2-month-old child with cough for 2 days and the respiratory syncytial virus positive, one of the multiple consolidation lesions with air bronchogram was located in the right upper lobe, and pleural effusion was also noted.Fig. 4

Follow-up {#sec0011}
---------

After antiviral therapy, 6 patients in the non-pregnant adult groups, 6 in the laboratory-confirmed pregnant group, and 8 patients in the clinically-diagnosed pregnant group, had follow-up CT. The time intervals from the initial CT ranged from 3 to 15 days. Nine patients (9/13) demonstrated mild progression at re-examined CT after 3 days, and 6 patients (6/8) demonstrated improvement 6--9 days after the initial CT scans. Four patients with progressive changes were performed with serial follow-up CT later till 13 days or 15 days since first CT. Three children had follow-up CT. No new lesion was found 9 days later in the child with normal initial CT, and her brother demonstrated improvement at CT on the same day. Another child showed improvement at the follow-up CT after 7 days.

Discussion {#sec0012}
==========

In the present study, we focused on investigating the clinical and chest CT imaging characteristics of the COVID-19 pneumonia in pregnant women and children, besides those from the non-pregnant adults. Our study revealed that the clinical symptoms of pregnant women were atypical in comparison with the non-pregnant adults. Leukocytosis (41%) and elevated neutrophil ratio (83%) were unusually noted for the COVID-19 cases. The consolidation lesions were more prevalent in the pregnant cases. The cases in the clinically-diagnosed pregnant group were vulnerable to more pulmonary involvement at CT in which disputes for aggravating the patients' status took place due to the possible false negative or postponed coronavirus nucleic acid tests. Therefore, it is commonly speculated that some delay in management was worrisome in order to wait for a confirmed diagnosis. For limiting the epidemic, chest CT has been playing an indispensable role in selection of the candidates for quarantine in Wuhan and other places in China. For children, the CT findings were diverse from normal appearances to a few lesions including GGO or consolidation in lungs.

The ongoing outbreak COVID-19 pneumonia demonstrated a relatively high contagion; meanwhile there are no specific therapeutic drugs and vaccines for the COVID-19. Early identification of COVID-19 is important for the patients as well as the healthy population. Currently, the patients should be isolated for treatment from the healthy people for controlling the epidemic. It has been reported that chest CT is superior to RT-PCR in sensitivity for early detection of COVID-19.[@bib0022] Based on the epidemiological characteristics, clinically-diagnosed cases with typical CT features were treated with the same therapy in Hubei Province to offset the effects of possible false negative of the new coronavirus nucleic acid tests.[@bib0013] In our study, 44% and 36% pregnant women presented initial onset of fever in either laboratory-confirmed or clinically-diagnosed group, which was less common than 87.9% in the non-pregnant population in the study by Guan et al.[@bib0011] and consistent with the previous study enrolling 9 pregnant women with COVID-19.[@bib0017] Currently, fever served as the basic screening flag in China. Absence of typical symptoms increased the difficulty of the surveillance in the pregnant population. Furthermore, the physiological findings about leukocytosis and elevated neutrophil ratio due to adaptations to gestation could further complicate the situation. Nevertheless, no pregnant women were admitted to ICU. Compared with the previous studies,[@bib0011] ^,^ [@bib0020] the patients' median age was much younger (30 years old) with fewer comorbidities in our study, thus it may be one of the reasons there were more cases of pregnant women categorized as mild or common type in clinical context.

As with unenhanced chest CT imaging of pregnant women during the epidemic in Wuhan, low dose technique was implemented with the DLP ranging from 50 to 150 mGy cm for diagnostic imaging in our study, which was safe for the fetuses.[@bib0023] Sixteen pregnant women were performed with post-partum CT in our study. As with the CT features associated with COVID-19 pneumonia, the common characteristics in the pregnant group included pure GGO, GGO with consolidation or reticulation, and complete consolidation with predominantly peripheral distribution and bilateral lung involvement, which were similar to those of the non-pregnant group in our research as reported in the previous studies.[@bib0019] ^,^ [@bib0020] ^,^ [@bib0024] There were overlaps in imaging findings between COVID-19 and other viral infections, such as the coronavirus SARS-CoV and MERS-CoV pneumonia, as well as H1N1, H5N1, and H7N9 infections.[@bib0019] ^,^ [@bib0020] The patterns of GGOs or GGO with the above features in predominantly peripheral distribution will facilitate the diagnosis of COVID-19 pneumonia.[@bib0020] The above imaging findings could be mostly explained by a recently published research on the pathological investigation of COVID-19.[@bib0025] Diffuse alveolar injury superimposed with cellular fibromyxoid exudates and hyaline membrane formation was identified on pathology. Other findings included pulmonary edema and interstitial mononuclear inflammatory infiltrates (dominated by lymphocytes). Therefore, we have the GGOs, consolidations, and reticulations which indicate fibromyxoid exudates, the interstitial edema and the lymphocytes infiltrate resulting in the lymphopenia inside the blood. The more common consolidation and relatively higher TSS in the laboratory-confirmed and clinically-diagnosed pregnant women suggested the more severity in pregnant women, except for three laboratory-confirmed pregnant women showing no abnormalities related with COVID-19 pneumonia at CT. Therefore, there is no doubt that the CT study did a big favor in structuring the clinical treatment strategy for the pregnant women as we hoped. Fortunately, the infants were all normal without any evidence of vertical transmission from women with COVID-19 pneumonia in late pregnancy, which was consistent with the prior research by Chen et al. [@bib0016]

While compared between the two pregnant groups, the consolidation were more frequent in the clinically-diagnosed group with a relatively higher TSS of 4·8 (SD 3·5), indicating relatively more severe lung involvement resulting from delayed treatment prior to a laboratory confirmation. Cases with initial negative RT-PCR for SARS-CoV-2 but high clinical suspicion were also reported in previous studies, and the SARS-CoV-2 was positive after repeated tests.[@bib0012] ^,^ [@bib0013] For the clinically-diagnosed patients, it is speculated that samples from the lower respiratory tract via lavage and repeat tests may be helpful to rule out the false negative results. Fortunately, the laboratory-negative cases with typical imaging findings were supposed to receive the same treatment protocol as the positive ones in China. Pleural effusion was identified in 6/16 (38%) and 6/25 (24%) patients in the laboratory-confirmed and clinically-diagnosed pregnant groups, which was more than that in the study by Song et al.[@bib0020] This phenomenon could be attributed to a common finding within 1--24 h of normal delivery. [@bib0026]

Compared with adults, fewer children are infected with SARS-CoV-2. Nine children younger than 14 years out of 1011 patients were reported by Guan et al.[@bib0011] Our study revealed that the non-specific abnormalities (pure GGO or consolidation) distributed without peripheral predominance at CT unlike the adults. However, when superimposed with other pathogen infections, the pulmonary involvement was more severe, as simultaneous infection of RSV and SARS-CoV-2 in one child was detected in our study. Nevertheless, it was difficult to distinguish if the consolidation was associated with COVID-19 pneumonia, since the consolidation and pleural effusion were also common in pure RSV infection.[@bib0027] The contact history and clinical symptoms of fever or cough may be helpful for the surveillance.

We performed the follow-up CT studies 3 days and 7 days after the initial CT. Compared with the previous studies,[@bib0024] ^,^ [@bib0028] most of the cases in our study demonstrated earlier progressive changes in lungs at first follow-up CT at 3 days. And most of them were witnessed to get improvements at second follow-up CT at about 7 days (6--9 days). Therefore, CT could be regarded as an efficient tool for the early detection and monitoring the dynamic evolution in the patients with COVID-19.[@bib0024]

Our study has several limitations. Firstly, the sample size was relatively small. Larger population from more centers should be warranted to validate our preliminary results. In addition, even though it\'s a study conducted in two centers, the majority of patients was from the hospital majoring in women and children, then the selection bias existed. Secondly, 22 pregnant women are outpatients, thus the follow-up CT images were absent for monitoring the therapeutic effects. Finally, for the pregnant woman and children, low dose technique was implemented so that the image quality was not so good as that of the non-pregnant adult group, but fortunately it\'s sufficient to evaluate the lesions.

In conclusion, our preliminary study demonstrated that the clinical findings of pregnant women with COVID-19 pneumonia were atypical, bringing about difficulties in early detection. The clinically-diagnosed pregnant cases shared similar chest CT features with the laboratory-confirmed ones, but with more severe consolidation lesions, and repeated SARS-CoV-2 tests should be implemented for these highly clinical suspicious patients, however, the negative tests will not hinder the management based on the typical clinical and imaging findings in clinical context where the COVID-19 is life-threatening. Chest CT study was the modality of choice for early detection, severity assessment, and monitoring the therapeutic effects with or without SARS-CoV-2 confirmation for this population. The chest CT imaging features of children with COVID-19 pneumonia were non-specific, while the exposure history and clinical symptoms could be more helpful for the screening.
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